scholarly journals Medical Management of Neurogenic Bladder for Children and Adults: A Review

2019 ◽  
Vol 25 (3) ◽  
pp. 195-204
Author(s):  
Elizabeth Lucas
Keyword(s):  
Quality Of Life ◽  
Neurogenic Bladder ◽  
Medical Management ◽  
Chronic Condition ◽  
Upper Urinary Tract ◽  
Urinary Continence ◽  
Clean Intermittent Catheterization ◽  
Successful Management ◽  
Bladder Drainage

Neurogenic bladder is a chronic condition affecting patients of all ages with significant medical and quality of life implications. Goals of treatment consist of protection of the upper urinary tract and promotion of reliable urinary continence. Successful management involves medications and most often bladder drainage via clean intermittent catheterization. This article reviews current literature on medical management to achieve goals of treatment.

Medical Management of Neurogenic Bladder

2017 ◽  
Author(s):  
Anne P Cameron ◽  
John T Stoffel
Keyword(s):  
Botulinum Toxin ◽  
Neurogenic Bladder ◽  
Urinary Continence ◽  
Nocturnal Polyuria ◽  
Combination Drug ◽  
Suitable Alternative ◽  
Bladder Drainage ◽  
Bladder Compliance ◽  
Cord Injury

In the management of neurogenic bladder (NGB), the goals are first and foremost to protect the upper tract from damage. The second treatment goal is to maintain urinary continence, but all the while maintaining the patient’s quality of life. These goals are achieved by treating most patients with NGB in a targeted fashion based on urodynamic findings. Medical therapy optimization and appropriate bladder drainage are the cornerstones of NGB management. Detrusor overactivity, poor bladder compliance, and incontinence related to these are best initially managed with antimuscarinic agents,; however, there is an increasing role for the new beta3 agonists. In the event these therapies fail, botulinum toxin is often the next choice; however,  is an expensive treatment, and some patients may be treated with combination drug therapy. Nocturnal polyuria is also extremely common in this group of patients and is quite bothersome. After other risk factors have been excluded, medical treatment with desmopressin may be a suitable alternative. This review contains 3 highly rendered figures, 2 tables, and 85 references Key words: adrenergic alpha blockers, antimuscarinics, botulinum toxin, desmopressin, imipramine, mirabegron, multiple sclerosis, neurogenic bladder, spinal cord injury

Medical Management of Neurogenic Bladder

2018 ◽  
Author(s):  
Anne P Cameron ◽  
John T Stoffel
Keyword(s):  
Botulinum Toxin ◽  
Neurogenic Bladder ◽  
Urinary Continence ◽  
Nocturnal Polyuria ◽  
Combination Drug ◽  
Suitable Alternative ◽  
Bladder Drainage ◽  
Bladder Compliance ◽  
Cord Injury

In the management of neurogenic bladder (NGB), the goals are first and foremost to protect the upper tract from damage. The second treatment goal is to maintain urinary continence, but all the while maintaining the patient’s quality of life. These goals are achieved by treating most patients with NGB in a targeted fashion based on urodynamic findings. Medical therapy optimization and appropriate bladder drainage are the cornerstones of NGB management. Detrusor overactivity, poor bladder compliance, and incontinence related to these are best initially managed with antimuscarinic agents,; however, there is an increasing role for the new beta3 agonists. In the event these therapies fail, botulinum toxin is often the next choice; however,  is an expensive treatment, and some patients may be treated with combination drug therapy. Nocturnal polyuria is also extremely common in this group of patients and is quite bothersome. After other risk factors have been excluded, medical treatment with desmopressin may be a suitable alternative. This review contains 3 highly rendered figures, 2 tables, and 85 references Key words: adrenergic alpha blockers, antimuscarinics, botulinum toxin, desmopressin, imipramine, mirabegron, multiple sclerosis, neurogenic bladder, spinal cord injury

EFFECT OF RECURRENT PYELONEPHRITIS AND NEUROGENIC BLADDER ON THE QUALITY OF LIFE OF CHILDREN WITH MYELODYSPLASIA

2020 ◽  
Vol 99 (1) ◽  
pp. 221-225
Author(s):  
M.A. Kosyreva ◽  
◽  
N.B. Guseva ◽  
A.A. Korsunskiy ◽  
A.I. Krapivkin ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Neurogenic Bladder
Sign in / Sign up

Export Citation Format

Share Document